Syndax Pharmaceuticals (SNDX) Non Operating Income: 2015-2020
Historic Non Operating Income for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Dec 2020 value amounting to -$563,000.
- Syndax Pharmaceuticals' Non Operating Income fell 374.63% to -$563,000 in Q4 2020 from the same period last year, while for Dec 2020 it was -$1.7 million, marking a year-over-year decrease of 216.29%. This contributed to the annual value of $20.9 million for FY2024, which is 1.55% up from last year.
- Syndax Pharmaceuticals' Non Operating Income amounted to -$563,000 in Q4 2020, which was up 3.60% from -$584,000 recorded in Q3 2020.
- Over the past 5 years, Syndax Pharmaceuticals' Non Operating Income peaked at $563,000 during Q2 2018, and registered a low of -$1.6 million during Q1 2016.
- For the 3-year period, Syndax Pharmaceuticals' Non Operating Income averaged around $139,333, with its median value being $336,500 (2018).
- Per our database at Business Quant, Syndax Pharmaceuticals' Non Operating Income spiked by 177.34% in 2018 and then crashed by 374.63% in 2020.
- Syndax Pharmaceuticals' Non Operating Income (Quarterly) stood at $326,000 in 2016, then climbed by 18.10% to $385,000 in 2017, then rose by 28.83% to $496,000 in 2018, then slumped by 58.67% to $205,000 in 2019, then slumped by 374.63% to -$563,000 in 2020.
- Its last three reported values are -$563,000 in Q4 2020, -$584,000 for Q3 2020, and -$452,000 during Q2 2020.